Paul Breillat: Targeting Inflammatory Cell Death Pathways in VEXAS Syndrome
Paul Breillat, Assistant Clinical Fellow in Internal Medicine and Clinical Immunology at Cochin Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Excited to share our new publication in Blood on VEXAS syndrome!
In this study, we uncover a pathogenic axis in VEXAS linking UBA1 loss of function and defective ubiquitination to:
- RIPK1-mediated inflammatory cell death
- Impaired antimicrobial signaling
- Defective resolution of inflammation
These findings provide evidence that targeting inflammatory cell death pathways represents a promising therapeutic strategy in VEXAS syndrome.
This work would not have been possible without our extraordinary collaborators David Beck, Samuel Magaziner, Stéphane Camus.
Warm thanks to the Foundation for Medical Research and Fonds IMMUNOV for their invaluable support.
Thanks also to the team at Paris Cardiovascular Research Center – PARCC and to INSERM for providing such a stimulating research environment.
Finally, special thanks to Benjamin Terrier for his mentorship and guidance throughout this project.”
Title: Inflammatory cell death and monocyte dysfunction in VEXAS syndrome
Authors: Paul Breillat, Samuel J Magaziner, Stéphane M. Camus, Léa Dionet, Benjamin De Valence De Minardiere, Pierre Sohier, Amine Majdi, Quentin Delcros, Federica Pallotti, Nadia Rivet, Kevin Chevalier, Margot Poux, Sr., Athena Lam, Pierre-Louis Tharaux, Olivia Lenoir, Abdelrahim Zoued, Olivier Kosmider, David B. Beck, Benjamin Terrier
Read the Full Article on Blood.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 4, 2026, 12:41Jecko Thachil: Interrupting Antiplatelet Therapy for Urgent and Planned Surgery
-
Mar 4, 2026, 08:40Wolfgang Miesbach։ Highlighting the Social and Psychological Impact of Factor VII Deficiency
-
Mar 3, 2026, 17:12Matteo Foschi: Cancer Worsens Prognosis after Breakthrough Ischemic Stroke Despite Oral Anticoagulation
-
Mar 3, 2026, 17:04Shiny K Kajal: Therapeutic Apheresis Is Redefining the Clinical Scope of Transfusion Medicine
-
Mar 3, 2026, 16:58Non-Carrier Mothers of Inv22 Hemophilia A Patients Frequently Harbor Additional F8 Gene Rearrangements – JTH
-
Mar 3, 2026, 16:53Valentina Rossi: Addressing Inflammation and Immune Mechanisms in Cardiomyopathy Management
-
Mar 3, 2026, 16:45Emmanuel J Favaloro: New Publication on Artificial Intelligence in Thrombosis and Hemostasis in CCLM
-
Mar 3, 2026, 16:32Scott E. Smith: Why Hematology Research Is the True Leader of all Medical Disciplines
-
Mar 3, 2026, 16:21Tareq Abadl: Why HIV Antibodies Stay Positive Even When Viral Load Is Zero?